Statistics for Protalix BioTherapeutics Inc (id:185 PLX)
Valuation metrics
Market cap
103.70M
Enterprise value
72.32M
Trailing P/E (ttm)
13.00
Forward P/E
2.27
PEG ratio
2.27
Price/Sales (ttm)
2.73
Price/Book (mrq)
3.62
Enterprise Value/Revenue
1.90
Enterprise Value/EBITDA
-5.35
Overview
Shares outstanding
73.54M
Float
54.66M
Shares short
3.10M
% Held by insiders
0.15%
% Held by institutions
0.07%
Average volume (10 days)
449.83K
Average volume (90 days)
Price summary
52-Week low
0.82
52-Week high
1.90
52-Week change
13.86%
Beta
0.67
50-Day moving average
1.10
200-Day moving average
1.18
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
December 20th, 2019
Ex-dividend date
Last split factor
2:1
Last split date
December 20th, 2019
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
-38.62%
Operating margin
-18.01%
Operational effectiveness
Return on assets
-10.27%
Return on equity
-43.48%
Income statement
Revenue (ttm)
0.52
Revenue per share (ttm)
0.52
Quarterly revenue growth (yoy)
Gross profit (ttm)
42.51M
EBITDA
12.94M
Net income to common (ttm)
-14,694,000.00
Diluted EPS (ttm)
-0.23
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
45.03M
Total cash per share (mrq)
0.61
Total debt (mrq)
26.15M
Total Debt/Equity (mrq)
91.50
Current ratio (mrq)
133.50%
Book value per share (mrq)
0.39
Cash flow
Cash flow statement
-2,715,000.00
Levered free cash flow (LFCF)
1.32M